Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Guardant Health, Inc. - Common Stock (NQ: GH )

42.63 +6.79 (+18.95%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
5 Top Stocks Cathie Wood Bought This Week
Despite a 50% YTD drawdown in ARKK, Cathie Wood has continued her purchases of high growth companies, such as TDOC and BILL stocks. 
Via InvestorPlace
Guardant Health to Report Second Quarter 2022 Financial Results on August 4, 2022
From Guardant Health, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Recap: Guardant Health Q4 Earnings
Guardant Health (NASDAQ:GH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:03 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Steve E. Krognes Joins Guardant Health Board of Directors
From Guardant Health, Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture
From Guardant Health, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022
Via Benzinga
Guardant Health to Participate in Upcoming June Investor Conferences
From Guardant Health, Inc.
Via Business Wire
First Guardant Health Liquid Biopsy Testing Service in Europe Now Operational at Vall d’Hebron Institute of Oncology
From Guardant Health, Inc.
Via Business Wire
Guardant Health to Present New Data from its Broad Portfolio of Blood Tests at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
From Guardant Health, Inc.
Via Business Wire
Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022
From Guardant Health, Inc.
Via Business Wire
90 Biggest Movers From Yesterday
Gainers 
Via Benzinga
10 Biggest Price Target Changes For Monday
Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading. 
Via Benzinga
What 6 Analyst Ratings Have To Say About Guardant Health
Over the past 3 months, 6 analysts have published their opinion on Guardant Health (NASDAQ:GH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
55 Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company. 
Via Benzinga
92 Biggest Movers From Friday
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the... 
Via Benzinga
Guardant Health Reports First Quarter 2022 Financial Results
From Guardant Health, Inc.
Via Business Wire
Guardant Health Announces Shield™ Blood Test Available in US to Detect Early Signs of Colorectal Cancer in Average-Risk Adults
From Guardant Health, Inc.
Via Business Wire
Guardant Health to Participate in the BofA Securities 2022 Healthcare Conference
From Guardant Health, Inc.
Via Business Wire
Guardant Health to Report First Quarter Financial Results on May 5, 2022
From Guardant Health, Inc.
Via Business Wire
Guardant Health Presents New Data Showing Blood Test Highly Accurate in Detecting Multiple Cancers at the American Association for Cancer Research Annual Meeting
From Guardant Health, Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Guardant Health Announces Partnership with Epic to Streamline Access to Company’s Broad Portfolio of Cancer Tests
From Guardant Health, Inc.
Via Business Wire
Guardant Health Response to Frivolous and Retaliatory Lawsuit Filed by Illumina
From Guardant Health, Inc.
Via Business Wire
Guardant Health Receives Regulatory Approval for Guardant360® CDx in Japan
From Guardant Health, Inc.
Via Business Wire
Guardant Health's Return On Capital Employed Overview
According to data from Benzinga Pro, during Q4, Guardant Health's (NASDAQ:GH) reported sales totaled $108.11 million. Despite a 32.75% increase in earnings, the company posted a... 
Via Benzinga
10 Biggest Price Target Changes For Thursday
SVB Leerink lowered Guardant Health, Inc. (NASDAQ: GH) price target from $170 to $140. Guardant Health shares dropped 5.7% to $56.22 in pre-market trading. 
Via Benzinga
Guardant Health Reports Fourth Quarter 2021 Financial Results and Provides 2022 Outlook
From Guardant Health, Inc.
Via Business Wire
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.